Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02261649 · ClinicalTrials.gov registry record
Impact of Cerebellar Mass Resection on Pain Processing
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 24
- Enrollment target
NCT02261649: Completed study, sponsored by Dana-Farber Cancer Institute.
NCT02261649 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02261649 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate how cerebellar resection surgery may affect pain sensation and the way the brain "reads" pain signals. By measuring brain activity in children and adolescents following surgery, the investigators hope to gain valuable information about pain processing in the brain.
Primary Outcome
Functional magnetic resonance imaging scans will be collected to measure blood oxygen level dependent (BOLD) responses, an indirect measure measure of neural activity. The Unit of Measure is % BOLD signal change across spatiotemporal domains within the brain.
Interventions
- OTHER Questionnaires
- DEVICE Medoc Advanced Medical Systems PATHWAY Model ATS
- PROCEDURE Cold water bath
- DEVICE MRI scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-12 |
What the finished NCT02261649 record still lists
NCT02261649 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Questionnaires is the first listed.
NCT02261649 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02261649 about?
NCT02261649 is a clinical study titled "Impact of Cerebellar Mass Resection on Pain Processing". The purpose of the study is to evaluate how cerebellar resection surgery may affect pain sensation and the way the brain "reads" pain signals. By measuring brain activity in children and adolescents following surgery, the investigators hope to gain valuable information about pain processing in the b...
What is the current status of trial NCT02261649?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2014-10. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02261649?
The interventions under investigation include: Questionnaires (OTHER), Medoc Advanced Medical Systems PATHWAY Model ATS (DEVICE), Cold water bath (PROCEDURE), MRI scanner (DEVICE).
Who is sponsoring clinical trial NCT02261649?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia